Autoimmunity Reviews

Article	Citations
Editorial Board	278
Editorial Board	180
“Fibromyalgia syndrome” related to Essure devices	153
Leflunomide: A safe and effective alternative in systemic lupus erythematosus	148
Proteomics and enriched biological processes in Antiphospholipid syndrome: A systematic review	112
Editorial Board	105
Characteristics and risk factors for infection in patients with ANCA-associated vasculitis: A systematic review and meta-analysis	100
T lymphocyte plasticity in chronic inflammatory diseases: The emerging role of the Ikaros family as a key Th17-Treg switch	94
The rationale for the use of corticosteroids in early severe Guillain-Barré syndrome	89
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence	84
Issues in autoantibody tests used in the classification criteria for autoimmune rheumatic diseases: the laboratory autoimmunologist's perspective	77
Epidemiological patterns and in-hospital mortality in ANCA-associated vasculitis: Insights from Spain's National Health Data (2016–2022)	76
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis	76
Lymphocyte activation gene-3 (LAG-3) regulatory T cells: An evolving biomarker for treatment response in autoimmune diseases	75
Osteonecrosis in systemic lupus erythematosus: Systematic insight from the epidemiology, pathogenesis, diagnosis and management	72
Susac syndrome: A scoping review	72
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders	72
The role of musculoskeletal ultrasound in difficult-to-treat RA: Insights from a systematic literature review	69
Endometriosis and autoimmunity	68
A call for uniformity in reporting patient level details during description of ophthalmologic major relapse among giant cell arteritis studies. A comment on article by Aussedat M et al. “Epidemiology	66
Editorial Board	66
Can anticoagulation be withdrawn in APS patients after aPL negativization?	65
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy	63
Seronegative autoimmune diseases: A challenging diagnosis	62
Conceiving complexity: Biological mechanisms underpinning the lasting effect of pregnancy on multiple sclerosis outcomes	57

Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered	57
Inflammatory bowel disease in primary immunodeficiency disorders is a heterogeneous clinical entity requiring an individualized treatment strategy: A systematic review	56
Autoimmunity in vitiligo: Therapeutic implications and opportunities	54
Fecal microbiota transplantation in autoimmune diseases – An extensive paper on a pathogenetic therapy	54
WITHDRAWN: Global incidence trends of autoimmune diseases from 1990 to 2021 and projections to 2050: A systemic analysis of the global burden of disease study 2021	51
Human abdominal aortic aneurysm (AAA): Evidence for an autoimmune antigen-driven disease.	51
Advances in precision medicine in imaging and therapeutic strategies for psoriatic disease	49
Autoimmune pre-disease	48
To treat or not to treat rheumatoid arthritis with glucocorticoids? A reheated debate	48
The impact of the COVID-19 pandemic on autoimmune diagnostics in Europe: A lesson to be learned	48
Understanding the effects of Janus kinase inhibitors on the cardiovascular system in comparison to main biological DMARDs in rheumatoid arthritis	46
Rebalancing redox homeostasis: A pivotal regulator of the cGAS-STING pathway in autoimmune diseases	46
Homocysteine as a trigger and potential therapeutic target for autoimmune diseases	45
Worsening of Graves' ophthalmopathy after SARS-CoV-2 mRNA vaccination	45
The immune system in Hashimoto's thyroiditis: Updating the current state of knowledge on potential therapies and animal model construction	42
Psychiatric manifestations of autoimmune encephalitis	42
Cardiovascular outcome in adult-onset Kawasaki disease	42
Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature	42
Indian Rheumatology Association guidelines for the management of ANCA associated vasculitis	41
Editorial Board	41
Refining search and keyword strategies in autoimmune ear disease bibliometric studies	41
A descriptive study of IgG4-related disease in children and young adults	40
Cerebral vasculitis as a clinical manifestation of neurosarcoidosis: A scoping review	40
Adipose failure through adipocyte overload and autoimmunity	40
Standardised interpretation of capillaroscopy in autoimmune idiopathic inflammatory myopathies: A structured review on behalf of the EULAR study group on microcirculation in Rheumatic Diseases	40
Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium	39
IFN-γ: An overlooked cytokine in dermatomyositis with anti-MDA5 antibodies	38
Specialized pro-resolving mediators and autoimmunity: Recent insights and future perspectives	38
Cancer incidence in primary Sjögren's syndrome: Data from the French hospitalization database	38
Systematic evaluation of the associations between schizophrenia and autoimmune diseases: An umbrella review	37
The genealogy, methodology, similarities and differences of immune reconstitution therapies for multiple sclerosis and neuromyelitis optica	36
Predicting autoimmune diseases: A comprehensive review of classic biomarkers and advances in artificial intelligence	36
A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases	36
Inclusion body myositis: Correcting impaired mitochondrial and lysosomal autophagy as a potential therapeutic strategy	36
Research progress on estrogen and estrogen receptors in the occurrence and progression of autoimmune thyroid diseases	34
Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: Opportunities and challenges	34
SpA plus IBD or IBD plus SpA: Does commutative property apply?	34
Editorial Board	33
Complex relationships of type 2 and type 1 symptoms across various systemic autoimmune diseases.	32
Are breast cancer patients diagnosed after systemic sclerosis showing different pathological characteristics?	32
The immune-neuroendocrine system in COVID-19, advanced age and rheumatic diseases	32
Controversies in in rheumatology and autoimmunity: Is CORA meeting a good educational tool to increase the scientific knowledge?	32
Effects of cytotoxic T-lymphocyte-associated protein 4 compared to TNF inhibitors on lipid profile: Results from an observational multicentre rheumatoid arthritis cohort	32
Factors associated with incident cardiovascular disease in patients with rheumatoid arthritis: A scoping review	31
Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines	31
Fibromyalgia: Are we using the biopsychosocial model?	31
Tumor necrosis factor-α inhibitor-related autoimmune disorders	31
Antibiotic-induced gut dysbiosis and autoimmune disease: A systematic review of preclinical studies	30
Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis	30
Development of an algorithm for IgG4-related disease management	30

The role of mitochondrial dysfunction in kidney injury and disease	30
Dysfunction of the glymphatic system and sleep disturbance in rheumatoid arthritis and musculoskeletal pain: A gap related to pain becoming chronic	29
Are IF-ANA the guiding light for SLE classification in the real-world setting?	29
Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease	29
Reply letter to letter to the editor	29
The myristoylated alanine-rich C-kinase substrates (MARCKS): A membrane-anchored mediator of the cell function	29
Editorial Board	29
Twenty shades of the mosaic of autoimmunity	28
Combination tacrolimus and ustekinumab therapy is effective in inducing clinical, biochemical and endoscopic remission in refractory moderate to severe ulcerative colitis	28
Will a hyperactive classical complement pathway exacerbate autoimmune diseases?	28
Anti-rods/rings autoantibodies in a patient with pancreatic injury	28
Mesenchymal stem cell in immunomodulation of dendritic cells: Implications for inflammatory bowel disease therapy	27
Global burden due to modifiable risk factors for autoimmune diseases, 1990–2021: Temporal trends and socio-demographic inequalities	27
Editorial Board	27
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechan	27
Editorial Board	27
Coffee consumption and risk of multiple sclerosis: A systematic review and meta-analysis	26
Rheumatological complications of Covid 19	26
A machine learning analysis to evaluate the outcome measures in inflammatory myopathies	26
Alarmins in autoimmune diseases	26
Differences in clinical phenotype, laboratory, and imaging manifestations between AQP4 IgG positive and AQP4 MOG IgG double negative NMOSD: How to correctly diagnose the two	26
Tumors, tumor therapies, autoimmunity and the eye	26
From autoantibody test results to decision making: Incorporating likelihood ratios within medical practice	25
In Memoriam: Pierre Youinou	25
Neuroimaging in thyroid eye disease: A systematic review	25
Mucous membrane pemphigoid	25
Editorial Board	25
Cutting edge confusion about cut-off settings in autoimmune diagnostics	24
Emerging role of Tissue Resident Memory T cells in vitiligo: From pathogenesis to therapeutics	24
The impact of pregnancy on future health in Rheumatoid Arthritis: A systematic review of the literature	24
Low-dose intravenous immunoglobulin (IVIg) in different immune-mediated conditions	24
Mucosal immunity and rheumatoid arthritis: An update on mechanisms and therapeutic potential	24
Reactive oxygen species: The Yin and Yang in (auto-)immunity	24
Subcutaneous tissue involvement in idiopathic inflammatory myopathies: Systematic literature review including three new cases and hypothetical mechanisms	23
Serum calprotectin is a marker of disease activity in Giant cell arteritis	23
Prevalence of immune-mediated inner ear disease in non-segmental vitiligo: A cross-sectional study	23
Editorial Board	23
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) in 2023	23
Risk factors associated with thrombocytopenia in systemic lupus erythematosus: A systematic review and meta-analysis	22
Differentially expressed genes in systemic sclerosis: Towards predictive medicine with new molecular tools for clinicians	22
Diagnostic approach in giant cell arteritis	22
Is it time for treat-to-target in antiphospholipid syndrome?	22
Potential immunological and genetic markers associated with lupus nephritis: From pathogenicity to therapeutic drug target	22
From inflammation to renal fibrosis: A one-way road in autoimmunity?	21
Prevention of rheumatoid arthritis: A systematic literature review of preventive strategies in at-risk individuals	21
JAK inhibitors and systemic sclerosis: A systematic review of the literature	21
Burden of inflammatory bowel disease among elderly, 1990–2019: A systematic analysis based on the global burden of disease study 2019	21
Development of systemic lupus erythematosus in patients with immune thrombocytopenic purpura: A systematic meta-analysis	21
Treatment of acute exacerbation in interstitial lung disease secondary to autoimmune rheumatic diseases: More questions than answers	21
Inflammatory muscle involvement in systemic vasculitis: A systematic review	21
Salivary gland involvement in ANCA-associated vasculitis	20
Genetic and genomic associations in antiphospholipid syndrome: A systematic review	20
Epidemiology of major relapse in giant cell arteritis: A study-level meta-analysis	20
Persistent aortic inflammation in patients with giant cell arteritis	20
Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data	20
Macrophages in Lupus Nephritis: Exploring a potential new therapeutic avenue	20
Persistence of antiphospholipid antibodies over time and its association with recurrence of clinical manifestations: A longitudinal study from a single centre	20
Structural cell heterogeneity underlies the differential contribution of IL-17A, IL-17F and IL-23 to joint versus skin chronic inflammation	19
Relapse rates and risk factors for unfavorable neurological prognosis of transverse myelitis in systemic lupus erythematosus: A systematic review and meta-analysis	19
Don't mix apples and oranges. Reply to Azoulay et al.	19
Editorial Board	19
COVID-19-related autoimmune disorders of central nervous system (CRAD-C): Is it a new entity?	19
Physical exercise therapy for autoimmune neuroinflammation: Application of knowledge from animal models to patient care	18
Drug-induced antiphospholipid syndrome: Analysis of the WHO international database	18
The emerging concept of ANCA-associated vasculitis related to inborn errors of immunity	18
Autoimmunity and COVID-19 – The microbiotal connection	18
Scleroderma cardiac crisis: A-life-threatening but reversible complication of systemic sclerosis	18
Glomerulonephritis and inflammatory bowel disease: A tale of gut-kidney axis dysfunction	18
Therapeutic potential of chimeric antigen receptor based therapies in autoimmune diseases	18
Safety and immunological proof-of-concept following treatment with tolerance-inducing cell products in patients with autoimmune diseases or receiving organ transplantation: A systematic review and met	18
Editorial Board	18
Identifying subsets of patients with undifferentiated connective tissue disease: Results from a prospective, real-world experience using particle-based multi-analyte technology	18
Research advances on targeted-Treg therapies on immune-mediated kidney diseases	17
Scleroderma specific autoantibodies and MS-like manifestations: A novel association?	17
The threat of triple M and autoimmune overlap syndromes with immune checkpoint inhibitors - A series of case reports	17
Inhibitors of Bruton's tyrosine kinase as emerging therapeutic strategy in autoimmune diseases	17
Intermittent fasting: A promising dietary intervention for autoimmune diseases	17
Clinical features, pathogenesis, and treatment of inflammatory bowel disease-associated spondyloarthritis	17
Cerebral iron accumulation in multiple sclerosis: Pathophysiology and therapeutic implications	17
Janus kinase inhibitors for psoriatic arthritis: Evidence from a systematic review and network meta-analysis	17

Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysis	16
Insights into new-onset autoimmune diseases after COVID-19 vaccination	16
Prevention of rheumatoid arthritis using a familial predictive medicine approach	16
Anti-glomerular basement membrane vasculitis	16
IgG4 in the gut: Gastrointestinal IgG4-related disease or a new subtype of inflammatory bowel disease	16
The interferon in idiopathic inflammatory myopathies: Different signatures and new therapeutic perspectives. A literature review	16
Advancing understanding of autoimmune disease-related interstitial lung disease (AD-ILD): A global perspective on research focus and future directions	16
Autoantibodies against tyrosyl-tRNA synthetase (anti-Ha antibodies)	16
Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus – A proposal from an expert panel	16
Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)	16
Emerging roles of mechanically activated ion channels in autoimmune disease	16
Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series	16
Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management	16
Involvement of aquaporin 5 in Sjögren’s syndrome	15
Letter to the editor regarding a meta-analysis of JAK inhibitors and psoriatic arthritis	15
Covid vaccination in patients with autoimmune diseases treated with mycophenolate: Let's think back to the recommendations	15
The role of bDMARDs in idiopathic inflammatory myopathies: A systematic literature review	15
Editorial Board	15
Exercise-induced modulation of Interferon-signature: a therapeutic route toward management of Systemic Lupus Erythematosus	15
Editorial Board	15
Severe treatment-refractory antibody positive autoimmune autonomic ganglionopathy and COVID19 vaccination: Correspondence	15
Outcomes of ICU patients treated with intravenous immunoglobulin for sepsis or autoimmune diseases	14
Global research landscape on antiphospholipid syndrome and systemic lupus erythematosus: Trends, collaborations, and future directions	14
Relapses in giant cell arteritis: Updated review for clinical practice	14
Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: A systematic review and meta-analysis	14
Takotsubo syndrome occurring in systemic diseases: A French multicenter retrospective case-control study and literature review	14
Pursuing appropriateness in antiphospholipid antibodies testing: Feasibility study with a reflex test approach for anti-β2GPI I domain	14
Effect of exercise training on fatigue and pain in patients with systemic autoimmune myopathies: A systematic review	14
Early skeletal muscle manifestations in polyarteritis nodosa and ANCA-associated vasculitis	14
Intravenous immunoglobulin as a therapy for autoimmune conditions	13
Autoimmune lymphoproliferative syndrome: A disorder of immune dysregulation	13
Multiple sclerosis and pregnancy: Pathogenesis, influencing factors, and treatment options	13
Corrigendum to “Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience” [Autoimmunity Reviews, Volume 20, Iss	13
The entrenchment of NLRP3 inflammasomes in autoimmune disease-related inflammation	13
Macrophage metabolic reprogramming: A trigger for cardiac damage in autoimmune diseases	13
Oxidative stress, mitochondrial dysfunction, and respiratory chain enzyme defects in inflammatory myopathies	13
From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapies	13
Cardiovascular risk in psoriatic arthritis: How can we manage it?	13
Does a window of opportunity for rheumatoid arthritis-associated interstitial lung disease exist?	13
Editorial Board	13
Single centre experience of 120 patients with non-infectious aortitis: Clinical features, treatment and complications	12
Letter to the editor: Keratitis fugax hereditaria is an eye-specific cryopyrin-associated periodic syndrome	12
Towards personalized management of myasthenia gravis phenotypes: From the role of multi-omics to the emerging biomarkers and therapeutic targets	12
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and exper	12
The role of interleukin inhibitors in the treatment of hidradenitis suppurativa; a systematic review of clinical trials	12
Exposome: Epigenetics and autoimmune diseases	12
Oligoclonal bands and kappa free light chains: Competing parameters or complementary biomarkers?	12
Comprehensive analysis of cell lineages involved in giant cell arteritis pathogenesis using highly multiplexed imaging mass cytometry	12
ChatGPT and autoimmunity – A new weapon in the battlefield of knowledge	12
Risk of venous thromboembolism in autoimmune diseases: A comprehensive review	12
Efficacy, safety, and tolerability of antifibrotic agents in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis	12
Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus	12
Editorial Board	12
Paraneoplastic autoimmune Laminin-332 syndrome (PALS): Anti-Laminin-332 mucous membrane pemphigoid as a prototype	12
Macrophage polarization regulates the pathogenesis and progression of autoimmune diseases	12
COVID-19, G protein-coupled receptor, and renin-angiotensin system autoantibodies: Systematic review and meta-analysis	12
Short-term and low-dose IL-2 therapy increases the reduced Treg cells in patients with microscopic polyangiitis	12
Contemporary advances in antibody-mediated encephalitis: anti-LGI1 and anti-Caspr2 antibody (Ab)-mediated encephalitides	11
Building a monitoring matrix for the management of multiple sclerosis	11
Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience	11
Circadian clock genes as promising therapeutic targets for autoimmune diseases	11
B and T cells: (Still) the dominant orchestrators in autoimmune hepatitis	11
Novel aspects of muscle involvement in immune-mediated inflammatory arthropathies and connective tissue diseases	11
The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort	11
ANCA and anti-glomerular basement membrane double-positive patients: A systematic review of the literature	11
Residual pain in rheumatoid arthritis: Is it a real problem?	11
Analysis of global prevalence, DALY and trends of inflammatory bowel disease and their correlations with sociodemographic index: Data from 1990 to 2019	11
Circulating and skin biopsy-present cytokines related to the pathogenesis of cutaneous lupus erythematosus	10
SLE patients with childhood-onset: A nation-wide population-based study	10
Framework for implementing treat-to-target in systemic lupus erythematosus routine clinical care: consensus statements from an international task force	10
IgA vasculitis in adult patient following vaccination by ChadOx1 nCoV-19	10
Arterial stiffness, the hidden face of cardiovascular risk in autoimmune and chronic inflammatory rheumatic diseases	10
Current state of epigenetics in giant cell arteritis: Focus on microRNA dysregulation	10
Unraveling the global burden of inflammatory bowel disease (1990–2019): A Joinpoint regression analysis of divergent trends in 10–24 and 50–69 age cohorts	10
Effects of nutritional supplements and dietary interventions on rheumatoid arthritis: An umbrella review of meta-analyses of randomized controlled trials	10
Key points to consider for an improved detection and characterization of cryoglobulins	10
Diagnostic yield of combined cranial and large vessel PET/CT, ultrasound and MRI in giant cell arteritis: A systematic review and meta-analysis	10
Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019	10
Aquaporins: Unexpected actors in autoimmune diseases	10
Is it safe to withdraw low-dose glucocorticoids in SLE patients in remission?	10
Association between breastfeeding and the risk of autoimmune diseases: A systematic review and meta-analysis	10
Renal involvement in systemic sclerosis	10
Autoreactive T cells of ankylosing spondylitis elicited by COVID-19 infection: A snapshot of immunological host defense and autoimmune imprinting	10
Social determinants of health and disparities across the patient pathway in systemic lupus erythematosus: A narrative review	10
Immunometabolic shifts in autoimmune disease: Mechanisms and pathophysiological implications	10
Anti-HMGCR immune-mediated necrotising myopathy: Addressing the remaining issues	10
Lung involvement in juvenile idiopathic inflammatory myopathy: A systematic review	9
Longitudinal monitoring of circulating immune cell phenotypes in anti-neutrophil cytoplasmic antibody-associated vasculitis	9
Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases?	9
Treatment strategies for Spondyloarthritis: Implementation of precision medicine – Or “one size fits all” concept?	9
Assessment and management for latent tuberculosis before advanced therapies for immune-mediated inflammatory diseases: A comprehensive review	9
Pathogenesis-based new perspectives of management of ANCA-associated vasculitis	9
Renal autoimmunity: The role of bacterial and viral infections, an extensive review	9
Autoimmune autonomic nervous system imbalance and conditions: Chronic fatigue syndrome, fibromyalgia, silicone breast implants, COVID and post-COVID syndrome, sick building syndrome, post-orthostatic	9
Letter to the editor: Prevalence of connective tissue disease autoantibodies in a large longitudinal population-based cohort from the Netherlands	9